Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease

[1]  V. Cantaluppi,et al.  Soluble Urokinase Receptor and Chronic Kidney Disease. , 2016, The New England journal of medicine.

[2]  M. Rastaldi,et al.  Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes , 2015, Scientific Reports.

[3]  A. Fogo.  Causes and pathogenesis of focal segmental glomerulosclerosis , 2015, Nature Reviews Nephrology.

[4]  M. Kretzler,et al.  A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease , 2014, Kidney international.

[5]  Ryan M. O’Connell,et al.  Conversion of Danger Signals into Cytokine Signals By Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis , 2014 .

[6]  M. Rastaldi,et al.  LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity , 2014, PloS one.

[7]  M. Sarwal,et al.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation , 2014, Science Translational Medicine.

[8]  M. Ploug,et al.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  F. Wang,et al.  Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis , 2014, BMC Medicine.

[10]  S. Dryer,et al.  Transient Receptor Potential Channel 6 (TRPC6) Protects Podocytes during Complement-mediated Glomerular Disease* , 2013, The Journal of Biological Chemistry.

[11]  Hani Suleiman,et al.  Rac1 Activation in Podocytes Induces Rapid Foot Process Effacement and Proteinuria , 2013, Molecular and Cellular Biology.

[12]  W. Stanford,et al.  Toll-Like Receptor 4/Stem Cell Antigen 1 Signaling Promotes Hematopoietic Precursor Cell Commitment to Granulocyte Development during the Granulopoietic Response to Escherichia coli Bacteremia , 2013, Infection and Immunity.

[13]  Huan Yang,et al.  The function of hematopoietic stem cells is altered by both genetic and inflammatory factors in lupus mice. , 2013, Blood.

[14]  G. Remuzzi,et al.  Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  D. Greiner,et al.  Humanized mice for immune system investigation: progress, promise and challenges , 2012, Nature Reviews Immunology.

[16]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[17]  D. Kotton,et al.  Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation , 2012 .

[18]  V. D’Agati,et al.  Focal segmental glomerulosclerosis. , 2011, The New England journal of medicine.

[19]  E. Salido,et al.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis , 2011, Nature Medicine.

[20]  V. Savin,et al.  Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[21]  E. Schon,et al.  Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. , 2010, The Journal of clinical investigation.

[22]  C. Alpers,et al.  BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[23]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[24]  C. Marshall,et al.  Regulation of cell signalling by uPAR , 2010, Nature Reviews Molecular Cell Biology.

[25]  Jesper Eugen-Olsen,et al.  suPAR: The Molecular Crystal Ball , 2009, Disease markers.

[26]  Kwanghee Kim,et al.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A , 2008, Nature Medicine.

[27]  P. Carmeliet,et al.  Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.

[28]  E. Haddad,et al.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. , 2007, Journal of the American Society of Nephrology : JASN.

[29]  A. Fogo.  Mechanisms of progression of chronic kidney disease , 2007, Pediatric Nephrology.

[30]  W. Stanford,et al.  Concise Review: Stem Cell Antigen‐1: Expression, Function, and Enigma , 2007, Stem cells.

[31]  M. Pericak-Vance,et al.  A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis , 2005, Science.

[32]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[33]  P. Eggers,et al.  Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  R. Kalluri,et al.  Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.

[35]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[36]  A. Dunn,et al.  Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. , 2002, Blood.

[37]  E. Bottinger,et al.  Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .

[38]  M. Bitzer,et al.  Apoptosis in podocytes induced by TGF-beta and Smad7. , 2001, The Journal of clinical investigation.

[39]  D. Link,et al.  Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. , 1996, Immunity.

[40]  S. Thorgeirsson,et al.  Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[41]  S. Swan,et al.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. , 1996, The New England journal of medicine.